David Monroy | Ocular Cancer | Best Researcher Award

David Monroy | Ocular Cancer | Best Researcher Award

Research Fellow at University of Miami in United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

profile

  • orcid

    Education :

    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

    Experience :

    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

    Awards and Honors :

    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

    Research Focus :

    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    David Monroy

    Short Biography (150 words):
    David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.


    Education (150 words):
    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.


    Experience (150 words):
    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.


    Awards and Honors (150 words):
    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.


    Research Focus (150 words):
    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    Publication Top notes :

    • 📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
    • 👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
    • 🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
    • 💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.

B Dayakar Rao | Food processing | Best Researcher Award

Dr. B Dayakar Rao | Food processing | Best Researcher Award

Principal scientist at Indian Institute of Millets Research in India

Dr. B. Dayakar Rao is a Principal Scientist at ICAR-Indian Institute of Millets Research (IIMR) and CEO of Nutrihub, an incubation center dedicated to promoting millet-based innovations. A leading figure in agricultural economics and food science, Dr. Rao has revolutionized the millet value chain by spearheading the Eatrite brand and fostering public-private partnerships to enhance millet processing, commercialization, and awareness. With his deep expertise, he has developed models that have been instrumental in shaping national millet policies, including INSIMP, which established 400 millet clusters across India. His contributions have significantly impacted farmer income, food security, and sustainable agriculture in India.

profile

  • scopus
  • orcid

    Education 

    Dr. B. Dayakar Rao’s educational journey reflects his deep commitment to agriculture and food economics. He earned his Ph.D. in Agriculture/Dairy Economics from the prestigious National Dairy Research Institute (NDRI), Karnal, India, in 1991, where his research focused on economic solutions in the agricultural sector. Prior to his doctoral studies, he completed his M.Sc. (Agri) in Agricultural Economics from Acharya NG Ranga Agricultural University (ANGRAU), Hyderabad, in 1987, gaining expertise in agricultural policy, economics, and sustainability. His foundation in agricultural sciences was laid during his undergraduate studies, when he earned a B.Sc. (Agri) in Agriculture and Allied Sciences from the same institution in 1985. These academic credentials have underpinned his career in pioneering millet research, technology, and value-chain development.

    Experience 

    Dr. B. Dayakar Rao has over three decades of experience in agricultural research and leadership. Currently, he is a Principal Scientist and the CEO of Nutrihub at ICAR-IIMR, Hyderabad, where he has served since 2008. His leadership at Nutrihub has transformed it into a premier incubation center for millet-based innovations. Prior to this, he was a Senior Scientist at the National Research Centre for Sorghum, Hyderabad, from 1996 to 2008, where he led impactful research in sorghum processing. From 1993 to 1996, he worked as a Scientist at the National Research Centre for Sorghum. His early career also included a stint at the Indian Institute of Horticultural Research (IIHR), Bangalore, in 1992-93, and at the National Academy of Agricultural Research Management (NAARM), Hyderabad.

    Awards and Honors

    Dr. B. Dayakar Rao has been recognized for his pioneering contributions to agricultural economics, millet research, and innovation. As a leader in millet value chain development, he has received numerous accolades, including awards for his work in the INSIMP initiative, which led to the establishment of 400 millet clusters across India. His leadership in public-private partnerships and entrepreneurship development in the millet sector has earned him widespread recognition. In addition, Dr. Rao has been acknowledged for his role in transforming Nutrihub into a premier incubation center, driving innovations in millet processing, commercialization, and nutritional value addition. His efforts have not only enhanced food security but also increased farmer incomes, contributing to sustainable agriculture in India.

    Research Focus 

    Dr. B. Dayakar Rao’s research primarily focuses on the economic development of underutilized crops like millets and sorghum. His groundbreaking work includes developing value chains for millet-based products, with a particular emphasis on production, processing, product innovation, commercialization, and marketing. Dr. Rao has also led research initiatives aimed at retrofitting processing machinery to suit millet crops and conducting nutritional evaluations to promote millet as a health food. His work on sorghum processing has established him as a national leader in this field, and his strategic insights into agricultural economics have helped shape India’s millet policy. His research aims to enhance sustainable agricultural practices, improve farmer livelihoods, and foster public-private partnerships that drive innovation in agriculture

    Publication Top notes

    • 🌾 “Millet Value Chain Development: Enhancing Farmer Incomes through Processing and Marketing”
    • 📊 “Economic Analysis of Sorghum Processing Technologies for Sustainable Agriculture”
    • 🚜 “INSIMP Initiative: Establishing 400 Millet Clusters Across India”
    • 🛠️ “Retrofitting Processing Machinery for Millets: Challenges and Innovations”
    • 🍽️ “Eatrite Brand: Commercializing Millets for a Healthier India”
    • 🌱 “Nutritional Evaluation of Millets: A Step Towards Food Security”
    • 💼 “Public-Private Partnerships in Millet Processing: Success Stories”
    • 🌾 “Sorghum Processing: A Model for Sustainable Agriculture”
    • 🏛️ “National Policies for Millet Promotion and Processing: A Vision for the Future”
    • 🏢 “Nutrihub: Transforming Agricultural Innovation Through Incubation”

Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Professor at Universität Tübingen, Tübingen Deutschland in Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.


Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉